A Minneapolis page on the website of R3 Stem Cell, a commercial network that markets donor cell and exosome injections through unnamed affiliated clinics.
R3 Stem Cell describes itself as a global leader in regenerative medicine offering stem cell and exosome therapies, with more than eighty locations across eight countries. What this directory lists as R3 Stem Cell Minneapolis is a page on that national website rather than a clinic with an identity of its own: it gives no Minneapolis street address, names no local clinician, and directs readers to a location finder to reach the nearest affiliated centre. The only contact route given is a national telephone number.
The products named across the site are broad: umbilical cord stem cells, amniotic tissue-derived material, bone marrow-derived cells, adipose (fat-derived) cells, platelet rich plasma (PRP, prepared from the patient's own blood), and exosomes together with what the site calls microsomes, secretomes and messenger ribonucleic acid (mRNA) from products of conception. Most of those are allogeneic — from a donor — rather than taken from the patient. The site states explicitly that it does not use cells from embryos or a fetus. It does not name its tissue suppliers or describe donor screening or processing.
The conditions listed are very wide. Alongside musculoskeletal problems such as arthritis, osteoarthritis, tendonitis, bursitis and degenerative disc disease, the site names autism, multiple sclerosis, Parkinson's disease, Alzheimer's disease, neuropathy, stroke, diabetes, chronic obstructive pulmonary disease (COPD), liver disease, erectile dysfunction and hair loss, and says the full site covers more than thirty conditions. That breadth deserves caution rather than confidence: the research position for injected cell products differs enormously between these conditions, and serious neurological and organ disease is not territory where such injections are established treatment.
The claims also need care. The site states that its centres have completed more than twenty-nine thousand stem cell procedures, and one page says treatment has been proven to eliminate certain conditions, without citing any data at all. The directory's rough notes quote an eighty-five per cent satisfaction rate; that figure does not appear on the pages reviewed. No prices are published. A large part of the Minneapolis page is general-interest filler about float tanks, acupuncture, massage and local restaurants rather than clinical information — a further reason to establish which clinic, which clinician and which product would actually be involved before committing to anything.
The list below is what the site names; its breadth across musculoskeletal, neurological and organ disease is itself something a reader should weigh.
The site names a wide range of cell and cell-derived products, most of them from donors rather than from the patient, and states that it does not use embryonic or fetal cells.
No clinician in Minneapolis is named; only the network's founder appears.
There is no facility described. The Minneapolis page gives no street address, no opening hours and no account of the premises, and instead points readers to a location finder to reach the nearest affiliated centre. Treatment would therefore be delivered at a partner clinic whose identity, staffing and standards are not disclosed on the page. Nothing is said about laboratory facilities, tissue storage or accreditation anywhere on the pages reviewed, and the cell products are supplied from elsewhere rather than prepared on site.
No prices appear on the pages reviewed. The directory's rough notes mention a free consultation and financing, but those statements are not on the site's own pages. Because the treating clinic is not identified, both the price and who sets it would have to be established by contacting the network first.
Profile compiled from information published on the clinic's own website and from the StemCell Registry directory record. Details may change; confirm directly with the clinic before making decisions.